iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Shares Down 0.3% – Should You Sell?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s stock price traded down 0.3% on Tuesday . The company traded as low as $25.32 and last traded at $25.36. 17,547 shares traded hands during trading, a decline of 41% from the average session volume of 29,520 shares. The stock had previously closed at $25.43.

iShares Genomics Immunology and Healthcare ETF Trading Down 0.3%

The business has a 50-day moving average price of $23.50 and a two-hundred day moving average price of $21.73. The stock has a market capitalization of $128.07 million, a P/E ratio of 14.76 and a beta of 1.07.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

A number of institutional investors have recently modified their holdings of the stock. Portland Global Advisors LLC acquired a new position in shares of iShares Genomics Immunology and Healthcare ETF during the 2nd quarter worth $2,099,000. Flow Traders U.S. LLC acquired a new position in shares of iShares Genomics Immunology and Healthcare ETF during the 2nd quarter worth $931,000. Finally, Cambridge Investment Research Advisors Inc. raised its holdings in shares of iShares Genomics Immunology and Healthcare ETF by 4.0% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 19,797 shares of the company’s stock worth $406,000 after buying an additional 756 shares in the last quarter.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.